Altogether, the results of these two studies clearly supported the hypothesis that treatment aimed at buffering the acidic tumor microenvironment, through the use of PPIs, that contrary to other drugs are activated in acidic conditions, may improve the effectiveness of CA-IX and reverse transcriptase inhibitors, significantly improving their antitumor effects. This evidence concerns the gene CA9 and neoplasm.